Results 211 to 220 of about 129,403 (228)

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Victoria Metaxa, Elie Azoulay   +2 more
exaly  

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

New England Journal of Medicine, 2021
Anthony C Gordon, Paul Mouncey, Farah Al-Beidh   +2 more
exaly  

The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV

Cell, 1988
John W Lowenthal
exaly  

Macrophage- and Dendritic-Cell-Derived Interleukin-15 Receptor Alpha Supports Homeostasis of Distinct CD8+ T Cell Subsets

Immunity, 2009
Erwan Mortier, Boris Reizis
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, Peter Willeit, Pei Gao
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy

New England Journal of Medicine, 2016
Christine Brown, Darya Alizadeh, Renate Starr   +2 more
exaly  

Anti-interleukin-2 receptor alpha for multiple sclerosis?

Lancet, The, 2013
Shiv Saidha, Peter A Calabresi
exaly  

Infertility in female mice lacking the receptor for interleukin 11 is due to a defective uterine response to implantation

Nature Medicine, 1998
Frank Koentgen
exaly  

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial

Lancet, The, 2008
Josef S Smolen, Andrea Rubbert-Roth, César R Ramos-Remus   +2 more
exaly